Pharmafile Logo

07 Good Pharma

Better for patients, better for business

Pharma is a dirty word to some. Even to those with milder views, it’s an industry often painted with an unenviable public image. Negative portrayals of massive conglomerates that happily trade patient wellbeing for profits are too frequently projected upon the pharmaceutical sector from those outside of it. Indisputably, pharma companies are powered by profit, but so is any business. Revenue pays salaries and overheads. It’s the lifeblood of any company, big or small. Why then, does pharma get such a bad rep?

Because it matters. Because we are an ageing population terrified by the concept of growing old. Because we are more aware of our lifestyle choices, more informed about serious illness and more concerned about what it means to us. Healthcare is vital to protecting that most sacred of human commodities; our lives. It’s a big responsibility and so it’s perhaps natural that, as a wider society, we’re critical of those charged with looking after us.

So who should run pharma – shareholders or stakeholders? Both. At Havas Lynx we are passionate about improving patients’ lives and we know that the pharmaceutical companies we work with share this commitment. We believe that the key to long-term success is finding a balance between making money and making a difference. By combining moral and commercial drivers, companies can breed a long-term financial security that allows continued investment in life-changing innovations.

This content was provided by Havas Lynx

Documents for download:

Company Details

 Latest Content from  Havas Lynx 

Havas Lynx celebrates 40 years of impact

Starting out in 1986 as a team of two in Manchester’s Northern Quarter, Havas Lynx has much to celebrate, having grown to become an international healthcare communications agency with offices…

Doctored Truths

When the truth is doctored, lives hang in the balance.

Climate of Health

What’s happening to our planet is having an undeniable and devastating impact across every aspect of human health. What harms the world, harms us all. And these effects are so…

Passion and Pain: Millennial HCP Report

When we investigate millennial healthcare professionals (HCPs), we see a generation experiencing a clash of two existences. On one hand, harness their passion and it’s like bottling lightening.  On the other, a more sobering story…

Health for All

Stories matter. They bind people together, create a sense of connection, and engage our thoughts, emotions, and imagination all at once. They show us other people’s perspectives and let us…

Doctored Truths urges pharma to lead the fight against health misinformation

“Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row….

Havas Lynx Welcomes New Leadership Hires

Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.

Havas to Open New Manchester Village at Circle Square

The global communications group will unite six agencies under one roof in a purpose-built, hybrid workspace at the heart of Manchester’s innovation district

Havas Lynx launches proprietary data product to drive meaningful change across pharma

Leading global healthcare communications agency, Havas Lynx , has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive…

Healing the Healers

Because if we do not heal the healers, who is going to heal us?